Qiagen Analyst Ratings
Qiagen Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 27.78% | JP Morgan | $55 → $50 | Maintains | Overweight |
| 09/26/2023 | 53.34% | Citigroup | $60 → $60 | Reiterates | Buy → Buy |
| 09/12/2023 | 27.78% | Baird | → $50 | Initiates Coverage On | → Outperform |
| 08/09/2023 | 22.67% | UBS | $50 → $48 | Maintains | Neutral |
| 02/09/2023 | 32.89% | UBS | $50 → $52 | Maintains | Neutral |
| 02/09/2023 | 53.34% | Citigroup | $55 → $60 | Maintains | Buy |
| 11/09/2022 | 40.56% | Citigroup | $62 → $55 | Maintains | Buy |
| 12/14/2021 | 53.34% | Wells Fargo | $58 → $60 | Maintains | Equal-Weight |
| 10/14/2021 | — | Redburn Partners | Initiates Coverage On | → Buy | |
| 07/14/2021 | 26.58% | Kepler Cheuvreux | → $49.53 | Downgrades | Buy → Hold |
| 06/03/2021 | 32.89% | Goldman Sachs | → $52 | Initiates Coverage On | → Neutral |
| 10/06/2020 | 50.78% | B of A Securities | → $59 | Upgrades | Neutral → Buy |
| 09/28/2020 | 51.6% | Kepler Cheuvreux | → $59.32 | Upgrades | Hold → Buy |
| 08/26/2020 | 68.67% | Commerzbank | → $66 | Upgrades | Hold → Buy |
| 08/24/2020 | 58.45% | Citigroup | $48 → $62 | Upgrades | Neutral → Buy |
| 08/20/2020 | 53.34% | JP Morgan | → $60 | Reinstates | → Overweight |
| 08/14/2020 | — | Exane BNP Paribas | Upgrades | Neutral → Outperform | |
| 08/14/2020 | 53.34% | Deutsche Bank | $32 → $60 | Upgrades | Hold → Buy |
| 04/02/2020 | 2.22% | Stifel | $33 → $40 | Maintains | Hold |
| 03/06/2020 | 7.33% | CFRA | $38 → $42 | Maintains | Hold |
| 02/06/2020 | -2.89% | CFRA | $40 → $38 | Maintains | Hold |
| 01/10/2020 | -8% | UBS | $39 → $36 | Maintains | Neutral |
| 01/08/2020 | -8% | Wells Fargo | → $36 | Initiates Coverage On | → Equal-Weight |
| 01/07/2020 | -10.55% | Citigroup | → $35 | Initiates Coverage On | → Neutral |
| 12/26/2019 | -28.44% | B of A Securities | → $28 | Reinstates | → Underperform |
| 11/18/2019 | 22.67% | Commerzbank | → $48 | Upgrades | Hold → Buy |
| 11/15/2019 | -15.67% | Stifel | → $33 | Initiates Coverage On | → Hold |
| 11/14/2019 | 2.22% | JP Morgan | $25 → $40 | Upgrades | Underweight → Overweight |
| 10/09/2019 | — | Kepler Cheuvreux | Downgrades | Hold → Reduce | |
| 10/08/2019 | -15.67% | B of A Securities | $40 → $33 | Maintains | Neutral |
| 10/08/2019 | -20.78% | Piper Sandler | $36 → $31 | Maintains | Neutral |
| 10/08/2019 | -36.11% | JP Morgan | $38 → $25 | Downgrades | Neutral → Underweight |
| 07/16/2019 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 03/15/2019 | 7.33% | UBS | → $42 | Initiates Coverage On | → Neutral |
| 10/31/2018 | 4.78% | Morgan Stanley | $39 → $41 | Maintains | Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/17/2023 | 27.78% | 摩根大通 | $55→$50 | 維護 | 超重 |
| 09/26/2023 | 53.34% | 花旗集團 | $60→$60 | 重申 | 購買→購買 |
| 09/12/2023 | 27.78% | 貝爾德 | →$50 | 開始承保 | →跑贏大盤 |
| 08/09/2023 | 22.67% | 瑞銀集團 | $50→$48 | 維護 | 中性 |
| 02/09/2023 | 32.89% | 瑞銀集團 | $50→$52 | 維護 | 中性 |
| 02/09/2023 | 53.34% | 花旗集團 | $55→$60 | 維護 | 買 |
| 11/09/2022 | 40.56% | 花旗集團 | $62→$55 | 維護 | 買 |
| 2021年12月14日 | 53.34% | 富國銀行 | $58→$60 | 維護 | 等重 |
| 10/14/2021 | - | Redburn合作夥伴 | 開始承保 | →購買 | |
| 07/14/2021 | 26.58% | 開普勒盛富銀行 | →$49.53 | 評級下調 | 購買→Hold |
| 06/03/2021 | 32.89% | 高盛 | →$52 | 開始承保 | →中性 |
| 10/06/2020 | 50.78% | B of A證券 | →$59 | 升級 | 中性→購買 |
| 09/28/2020 | 51.6% | 開普勒盛富銀行 | →$59.32 | 升級 | 持有→購買 |
| 2020/08/26 | 68.67% | 德國商業銀行 | →$66 | 升級 | 持有→購買 |
| 08/24/2020 | 58.45% | 花旗集團 | $48→$62 | 升級 | 中性→購買 |
| 08/20/2020 | 53.34% | 摩根大通 | →$60 | 恢復 | →超重 |
| 2020/08/14 | - | 法國巴黎銀行 | 升級 | 中性→表現優異 | |
| 2020/08/14 | 53.34% | 德意志銀行 | $32→$60 | 升級 | 持有→購買 |
| 04/02/2020 | 2.22% | Stifel | $33→$40 | 維護 | 保持 |
| 03/06/2020 | 7.33% | CFRA | $38→$42 | 維護 | 保持 |
| 02/06/2020 | -2.89% | CFRA | $40→$38 | 維護 | 保持 |
| 2020/10/01 | -8% | 瑞銀集團 | $39→$36 | 維護 | 中性 |
| 1/08/2020 | -8% | 富國銀行 | →$36 | 開始承保 | →等重 |
| 1/07/2020 | -10.55% | 花旗集團 | →$35 | 開始承保 | →中性 |
| 2019年12月26日 | -28.44% | B of A證券 | →$28 | 恢復 | →表現不佳 |
| 2019年11月18日 | 22.67% | 德國商業銀行 | →$48 | 升級 | 持有→購買 |
| 2019年11月15日 | -15.67% | Stifel | →$33 | 開始承保 | →保留 |
| 2019年11月14日 | 2.22% | 摩根大通 | $25→$40 | 升級 | 減持→超重 |
| 2019年10月09日 | - | 開普勒盛富銀行 | 評級下調 | 按住→減量 | |
| 2019年10月08日 | -15.67% | B of A證券 | $40→$33 | 維護 | 中性 |
| 2019年10月08日 | -20.78% | 派珀·桑德勒 | $36→$31 | 維護 | 中性 |
| 2019年10月08日 | -36.11% | 摩根大通 | $38→$25 | 評級下調 | 中性→減持 |
| 2019年07月16日 | - | Evercore ISI集團 | 評級下調 | 勝過→同線 | |
| 2019年03月15日 | 7.33% | 瑞銀集團 | →$42 | 開始承保 | →中性 |
| 2018年10月31日 | 4.78% | 摩根士丹利 | $39→$41 | 維護 | 超重 |
What is the target price for Qiagen (QGEN)?
奇根(QGEN)的目標價是多少？
The latest price target for Qiagen (NYSE: QGEN) was reported by JP Morgan on October 17, 2023. The analyst firm set a price target for $50.00 expecting QGEN to rise to within 12 months (a possible 27.78% upside). 7 analyst firms have reported ratings in the last year.
JP摩根於2023年10月17日報道了啟元(紐約證券交易所代碼：QGEN)的最新目標價。這家分析公司將目標價定為50美元，預計QGEN將在12個月內升至(可能上漲27.78%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Qiagen (QGEN)?
分析師對QGEN的最新評級是多少？
The latest analyst rating for Qiagen (NYSE: QGEN) was provided by JP Morgan, and Qiagen maintained their overweight rating.
JP摩根對奇根(紐約證券交易所代碼：QGEN)的最新分析師評級是由摩根大通提供的，奇根維持其增持評級。
When is the next analyst rating going to be posted or updated for Qiagen (QGEN)?
QGEN的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Qiagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Qiagen was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
分析師在進行了廣泛的研究後得出了股票評級，這些研究包括查閱公共財務報表，與啟元的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。對Qiagen的上一次評級是在2023年10月17日提交的，所以你應該預計下一次評級將在2024年10月17日左右提供。
Is the Analyst Rating Qiagen (QGEN) correct?
分析師對齊根(QGEN)的評級正確嗎？
While ratings are subjective and will change, the latest Qiagen (QGEN) rating was a maintained with a price target of $55.00 to $50.00. The current price Qiagen (QGEN) is trading at is $39.13, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的啟元(QGEN)評級維持不變，目標價在55.00美元至50.00美元之間。QGEN目前的交易價格為39.13美元，超出了分析師的預測區間。